Dana Pizzuti, Chief Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 20,712 shares at $16.15 ($334K) on 2023-04-05, disclosed to the SEC on 2023-04-05.
Scheduled sale ($334k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.98 | 4,288 | $69K | 20.5% |
| 2 | $16.15 | 8,212 | $133K | 39.7% |
| 3 | $16.15 | 8,212 | $133K | 39.7% |
| Total | $16.11 avg | 20,712 | $334K | 100% |
| Filing → |
| CRNX | SELL | 2025-10-03 | $209K | — | Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |